The PennZone

  • Home
  • Business
  • Health
  • Construction
  • Financial
  • Automotive
  • Technology
  • Music
  • Books

ExpressCells to Present in BIO Start-Up Stadium Next Week
The PennZone/10070540

Trending...
  • BumblebeeSmart Introduces Rounded Busy Board Set for Preschoolers
  • Dispelling Holiday Suicide Myth: CDC Data Shows Suicide Rates Lowest in December; International Survivors of Suicide Day Emphasizes Need for Action
  • New Smile Now Introduces RAYFace 3D Scanner to Advance Digital Surgery
Company is one of 30 selected for prestigious competition. During BIO Digital Week, attendees can watch timely, on-demand pitches and meet with ExpressCells via BIO's One-on-One Partnering.

PHILADELPHIA - PennZone -- ExpressCells, Inc. (ExpressCells), a privately-owned genetic engineering company that creates knock-in cell lines for drug discovery, will be one of the finalists presenting in the Start-Up Stadium during BIO Digital Week.

"We are honored to be selected by the judges as one of the finalists for Start-Up Stadium. We hope that all BIO Digital Week attendees view our presentation, which will be available on demand via the meeting platform."

Start-Up Stadium provides an exciting and interactive experience where key stakeholders of the early-stage life science community, investors, and strategic partners provide feedback and judge 6 minute pitches presented by start-up biotech companies. During BIO Digital Week, attendees can watch ExpressCells' pitch on-demand and meet with the company via BIO's One-on-One Partnering.

More on The PennZone
  • Men's Health Network Announces a New Feature to Support the Well-Being of Men When and Where They Are through Text Alerts
  • Comp-U-Floor Unveils Powerful New Commercial Module
  • Revenue Optics Announces the Appointment of Sonal Chowdhury as Senior Manager – Strategic Operations
  • How California Convinces Buyers Not to Purchase New Cars — and How This Hurts Dealers
  • Tax Fears and Political Volatility Drive Wealthy UK Residents to Consider Leaving, La Vida Survey Shows

"ExpressCells is excited to be part of BIO Digital Week," Mr. Handel continued. "We hope to gain valuable feedback and to meet with both potential customers and potential investors.

About ExpressCells

ExpressCells is a private biotechnology company based in Philadelphia, PA. Its propriety genome editing technology, in combination with CRISPR/Cas9, creates advanced, knock-in cell line up to 75% faster than older processes. This technology allows ExpressCells to insert up to three genes into the same cell line.

ExpressCells' first knock-in cell lines code for bioluminescent and fluorescent proteins. These allow scientists to more see the results of their experiments in real time. ExpressCells sells both custom cell lines—each designed to meet the specific requirements of an individual scientist—and catalog cell lines. For more information, visit www.xpresscells.com.

Contact
Matthew Handel
***@xpresscells.com
+1 (484) 483-6759


Source: ExpressCells, Inc.

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Global Preschool Giants Unite to Celebrate the 12th Anniversary of Badanamu's Hit Song "Ponytail"
  • America's Leading Annuity Expert Carlton Cap Averil II Joins Tom Hegna on "Financial Freedom with Tom Hegna"
  • Cheeron Partners with CRCC to Support Shanghai East Railway Station
  • MiBoxer Shines at 2025 Hong Kong International Lighting Fair, Intelligent Lighting Solutions Acclaimed by Global Clients
  • Anern Launches the AN-SLZ2 Smart Integrated Solar Street Light
  • "Nikko Kitchen," Tochigi Prefecture's New Gourmet Eatery, has Opened Near Tobu Nikko Station
  • Michael Gi Delivers Inspiring New Gospel Releases That Lift Hearts and Honor Legacy
  • Ashley Wineland To Release Scorching Single and Film Noir Cinematic Video for 'Love Letter'
  • Chuckie F. Mahoney Memorial Foundation Funds Program to Curb Cyber Bullying in Burgettstown Schools
  • Why Gourmet Steaks Are the Perfect Holiday Gift
  • Together We Dance Foundation Thrives Through Donor and Athlete Support
  • Platinum Plumbing Launches First Veteran Hot Water Heater Giveaway to Honor Local Heroes
  • Cut Costs & Boost Profits with the First Major Upgrade in 30 YEARS Replacing Rotary Lasers and Historic Clear Tube Altimeter Bubbles
  • Inframark Expands Its Specialized Automation and Intelligence Capabilities, Adds Dmytryka Jacobs Engineers
  • Sustainable Santa Returns to Old Sacramento
  • Upcoming Launch of Retail Crypto Cloud Mining Platform with Daily Rewards in a Transparent Revenue-Share Model: iMD Companies, Inc. Stock Symbol: ICBU
  • BumblebeeSmart Introduces Rounded Busy Board Set for Preschoolers
  • CRH Healthcare Opens 100th Urgent Care Clinic with Second Peachtree Immediate Care Location in Covington
  • COHN Named Colorado State-Approved Vendor for Advertising & Marketing Services
  • The Kryder Law Group, LLC Report Reveals Commercial Air Travel Is Safer Than You Think

Popular on PennZone

  • J French's #1 Album "I Don't Believe in Bad Days" Enters the Grammy Conversation
  • Literary fiction novel- 'Skylark' wins Bronze Medal
  • Bookmakers Review Releases 2028 Democratic Nominee Betting Odds: Newsom Leads Early Field
  • Assent Recognizes Manufacturers for Leading Supply Chain Sustainability Programs
  • Kilmer Construction Announces Seasonal Savings on Home Improvements in Northeastern PA
  • Local Boyertown Auto Shop Announces Expansion Due to Overwhelming Customer Demand
  • Taboo: The Lost Codes of Men — A Bold New Book Confronting the Crisis of Modern Manhood
  • Dongsheng's Titanium Recycling Business Enters Aerospace Sector by 2025
  • Frost Locker: New Research Reveals Mild Cold—Not Extreme Cold—Delivers Real Health Benefits of Cold Therapy
  • OddsTrader Reveals Early Favorites and Best Bets to Win March Madness 2026

Similar on PennZone

  • Revenue Expansion, Regulatory Momentum, and a Leadership Position in the $750 Million Suicidal Depression: NRx Pharmaceuticals (N A S D A Q: NRXP)
  • $750 Million Market on Track to $3.35 Billion by 2034: $NRXP Launches First-in-Florida "One Day" Depression Treatment in Partnership with Ampa Health
  • $750 Million Market Set to Soar to $3.35 Billion by 2034 as Florida Launches First-in-Nation One-Day: NRx Pharmaceuticals (N A S D A Q: NRXP) $NRXP
  • U.S. Entrepreneur Anjo De Heus Builds Innovation Bridge Between America and the Gulf
  • Global Innovators Take the Stage at the WorldUpstart Accelerator Showcase in Philadelphia
  • Phinge's Netverse to Redefine Clinical Trial Safety and Data Integrity with Netverse Patented, Hardware-Verified Platform
  • MDRN MUSE Expands Insurance Network Coverage to Include Delta Dental & Cigna
  • New You Smile Dental Implant Center Expands Office
  • Restoration Dental Introduces YOMI Robot for High-Precision Implant Surgery in Oklahoma
  • Dr. Frederic Scheer to Speak at Big Sky AI Forum in Bozeman, Montana
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us